Early-stage stomach cancer diagnoses increased by about 53% between 2004 and 2021, according to a study published May 3 in Gastrointestinal Endoscopy and presented at the 2025 Digestive Disease Week annual meeting.
Here are three notes on the study:
- As early-stage diagnoses increased, diagnoses of more advanced stomach cancer cases “dropped significantly,” according to a May 3 news release.
- Cleveland Clinic researchers utilized the National Cancer Institute’s Surveillance, Epidemiology and End Results data for their analysis.
- Mohamed Tausif Siddiqui, MD, a gastroenterology fellow at Cleveland Clinic and lead study author, said the findings may be attributed to increased uptake of early detection strategies and newer endoscopic technologies.
Read the full study here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.